Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM.
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet.
2013 Sep 14
Comments on News and Primary Papers
Primary Papers: Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.Comment by: Irving Gottesman, SRF Advisor
Submitted 24 July 2013
Posted 31 July 2013
I recommend this paper
A landmark paper (note the 140-page Appendix online) with sophisticated data analytics beyond my competence. As John Davis, doyen of American psychopharmacology, is senior author, I have confidence in the bottom line. My own preference would have been to omit patients with delusional disorder from the meta-analyses, as they may have added noise. I am not aware of any strong genetic evidence that delusional disorder is related to schizophrenia.
View all comments by Irving Gottesman